Most Read News

Shilpa Medicare said it has completed Phase 3 trials for SMLNUD07 – Nor Ursodeoxycholic Acid (Nor UDCA) tablets in 165 NAFLD patients in India.

On a YoY basis, revenue from operations grew to ₹2,244.9 crore from ₹2,017.2 Cr in Q3 FY24, which translates to an 11.3% increase, indicating steady run-rate business growth

HAL announced its first interim dividend of ₹25 per equity share for FY25, totaling a payout of over ₹1,600 crore.

On a consolidated basis, revenue rose 6.7% YoY to ₹2.40 lakh crore, up from ₹2.25 lakh crore in the corresponding quarter last year.

A look at what stocks the Big-10 Mutual Fund Houses are buying and selling in January 2025

EBITDA came in at ₹100.1 crore down 9.6% YoY compared to ₹110.7 crore reflecting operating margin pressure.

While food inflation is perceptibly lower in January 2025, there has been a rebound in core inflation

So far, the firm had invested about $5 million on pre-development work for a 484 MW wind farm in Mannar and Pooneryn and on the development of Sri Lanka’s 220 KV and 400 KV transmission network.

Here are some of the stocks that may see significant price movement today: Paytm, Bank of Baroda, Kalpataru Project, etc.

EBITDA margin improved to 11.2% vs. 9.7% last year, reflecting better cost management and higher profitability.